Mass General Brigham Plan Drops Medicare Advantage Coverage for Dana-Farber Cancer Patients
Mass General Brigham's health plan has discontinued Medicare Advantage coverage for Dana-Farber Cancer Institute patients, coinciding with the organizations ending their long-standing partnership. The contract lapse affects Medicare Advantage enrollees who previously had in-network access to Dana-Farber oncology services through MGB's health plan. The change is effective as the two organizations wind down decades of clinical collaboration. This development impacts network adequacy and patient access for Medicare Advantage beneficiaries in the Boston market.
While this involves Medicare Advantage rather than Medicaid managed care, it illustrates network disruption dynamics that could affect dual-eligible beneficiaries and reflects broader health system realignment trends in New England.
Managed Care
You might also like